Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research.
- DOI
- 10.1093/ajrccm/aamag370
- Published
- 2026 Jul 11
- Container
- American journal of respiratory and critical care medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ajrccm/aamag370,
title = {Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research.},
author = {Gramegna A and Putti G and Alicandro G and Mall MA and Blasi F},
year = {2026},
journal = {American journal of respiratory and critical care medicine},
doi = {10.1093/ajrccm/aamag370},
url = {https://doi.org/10.1093/ajrccm/aamag370}
}RIS
TY - JOUR TI - Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research. AU - Gramegna A AU - Putti G AU - Alicandro G AU - Mall MA AU - Blasi F PY - 2026 JO - American journal of respiratory and critical care medicine DO - 10.1093/ajrccm/aamag370 UR - https://doi.org/10.1093/ajrccm/aamag370 ER -
APA
A, G., G, P., G, A., MA, M., & F, B. (2026). Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research.. American journal of respiratory and critical care medicine. https://doi.org/10.1093/ajrccm/aamag370
Source records
- pubmed · retrieved 2026-09-25T07:05:33.021Z